Clinical Trials Directory

Trials / Completed

CompletedNCT02593799

Non-invasive Prediction of Esophageal Varices in Liver Cirrhosis: A Multicenter Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
363 (actual)
Sponsor
General Hospital of Shenyang Military Region · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Esophageal variceal bleeding is one of the most lethal complications of liver cirrhosis. In the early stage of liver cirrhosis, the prediction of esophageal varices is very important for guiding the clinical decision making of primary prophylaxis of variceal bleeding.

Detailed description

Esophageal variceal bleeding is one of the most lethal complications of liver cirrhosis. In the early stage of liver cirrhosis, the prediction of esophageal varices is very important for guiding the clinical decision making of primary prophylaxis of variceal bleeding. The investigators' recent systematic review evaluated the diagnostic accuracy of APRI, AAR, FIB-4, FI, King, Lok, Forns, and FibroIndex scores in predicting the presence of esophageal varices in liver cirrhosis. However, their diagnostic accuracy was low to moderate. Further study is warranted to establish a reliable score to predict the presence of high-risk esophageal varice in liver cirrhosis.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopyUpper gastrointestinal endoscopy to evaluate the presence of any grade varices and high-risk varices.

Timeline

Start date
2015-05-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2015-11-02
Last updated
2019-02-04

Locations

17 sites across 1 country: China

Source: ClinicalTrials.gov record NCT02593799. Inclusion in this directory is not an endorsement.